dapagliflozin
astrazeneca
[]
the role of sglt2 inhibitors already has and continues to evolve now, solidifying its role in #hfpef. learn more about the deliver trial from #esccongress: 
https://t.co/oO8rFDu0YA is an online medical news website dedicated to providing clinically impactful news related to endocrinology.